Pain Therapeutics, Inc. (NASDAQ:PTIE)
CAPS Rating:
A biopharmaceutical company that develops novel drugs for pain management and oncology.
The World's Greatest Investing Community
A biopharmaceutical company that develops novel drugs for pain management and oncology.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Two products in phase 3 clinical trials for pain which is a very large market. Both of these products are variations on currently marketed painkillers so there is a high probability that the trials will be successful (one is an abuse-resistant variation, the other is addiction-resistant). Also, they have lots of cash.